Annual Working Capital
$204.61 M
-$70.75 M-25.69%
31 December 2023
Summary:
Repare Therapeutics annual working capital is currently $204.61 million, with the most recent change of -$70.75 million (-25.69%) on 31 December 2023. During the last 3 years, it has fallen by -$130.93 million (-39.02%). RPTX annual working capital is now -39.02% below its all-time high of $335.54 million, reached on 31 December 2020.RPTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$169.32 M
-$27.77 M-14.09%
30 September 2024
Summary:
Repare Therapeutics quarterly working capital is currently $169.32 million, with the most recent change of -$27.77 million (-14.09%) on 30 September 2024. Over the past year, it has dropped by -$56.80 million (-25.12%). RPTX quarterly working capital is now -53.92% below its all-time high of $367.47 million, reached on 30 June 2020.RPTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.7% | -25.1% |
| 3 y3 years | -39.0% | -34.1% |
| 5 y5 years | +1917.2% | - |
RPTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.0% | at low | -48.5% | at low |
| 5 y | 5 years | -39.0% | +1917.2% | -53.9% | +110.1% |
| alltime | all time | -39.0% | +1917.2% | -53.9% | +110.1% |
Repare Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $169.32 M(-14.1%) |
| June 2024 | - | $197.09 M(-12.1%) |
| Mar 2024 | - | $224.10 M(+9.5%) |
| Dec 2023 | $204.61 M(-25.7%) | $204.61 M(-9.5%) |
| Sept 2023 | - | $226.12 M(-5.3%) |
| June 2023 | - | $238.67 M(-2.4%) |
| Mar 2023 | - | $244.59 M(-11.2%) |
| Dec 2022 | $275.36 M | $275.36 M(-16.2%) |
| Sept 2022 | - | $328.73 M(+31.3%) |
| June 2022 | - | $250.30 M(-12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $285.14 M(-9.9%) |
| Dec 2021 | $316.32 M(-5.7%) | $316.32 M(+23.1%) |
| Sept 2021 | - | $256.97 M(-10.1%) |
| June 2021 | - | $285.96 M(-9.4%) |
| Mar 2021 | - | $315.79 M(-5.9%) |
| Dec 2020 | $335.54 M(+255.7%) | $335.54 M(-4.4%) |
| Sept 2020 | - | $351.07 M(-4.5%) |
| June 2020 | - | $367.47 M(+356.0%) |
| Mar 2020 | - | $80.58 M(-14.6%) |
| Dec 2019 | $94.33 M(+830.0%) | $94.33 M |
| Dec 2018 | $10.14 M | - |
FAQ
- What is Repare Therapeutics annual working capital?
- What is the all time high annual working capital for Repare Therapeutics?
- What is Repare Therapeutics annual working capital year-on-year change?
- What is Repare Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Repare Therapeutics?
- What is Repare Therapeutics quarterly working capital year-on-year change?
What is Repare Therapeutics annual working capital?
The current annual working capital of RPTX is $204.61 M
What is the all time high annual working capital for Repare Therapeutics?
Repare Therapeutics all-time high annual working capital is $335.54 M
What is Repare Therapeutics annual working capital year-on-year change?
Over the past year, RPTX annual working capital has changed by -$70.75 M (-25.69%)
What is Repare Therapeutics quarterly working capital?
The current quarterly working capital of RPTX is $169.32 M
What is the all time high quarterly working capital for Repare Therapeutics?
Repare Therapeutics all-time high quarterly working capital is $367.47 M
What is Repare Therapeutics quarterly working capital year-on-year change?
Over the past year, RPTX quarterly working capital has changed by -$56.80 M (-25.12%)